The purpose of this study is to investigate treatment options for borderline resectable and locally advanced pancreatic cancer. This study investigates how different treatments may improve outcomes for these conditions.
The study focuses on evaluating the effectiveness of primary chemotherapy followed by possible surgical procedures. It evaluates how these treatments may affect resectability rates and overall survival.
- Who can participate: Adults over 18 years with borderline resectable or locally advanced adenocarcinoma of the pancreas can participate. Participants must be able to receive primary chemotherapy and potential surgery.
- Study details: Participants will receive primary chemotherapy and may undergo surgical exploration and resection. The study follows national guidelines for treatment.
How understandable was the trial content above?
Hard to understand
Easy to understand